<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome (APS) is defined broadly by the presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo>, venous and <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo>, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> and fetal wastage </plain></SENT>
<SENT sid="1" pm="."><plain>APS can be primary or secondary, in which APS occurs in the context of another defined disease such as <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo>, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>, drug-induced disease, etc </plain></SENT>
<SENT sid="2" pm="."><plain>APS is primary in one-half of patients and secondary in the rest, mainly to <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Several cardiac manifestations of APS have been reported </plain></SENT>
<SENT sid="4" pm="."><plain>These include <z:hpo ids='HP_0001654'>valvular heart disease</z:hpo>, <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo>, intracardiac <z:mp ids='MP_0005048'>thrombosis</z:mp> and <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The literature has shown a prevalence of approximately 35% of <z:hpo ids='HP_0001654'>valvular abnormalities</z:hpo> detected by echocardiography in patients with APS </plain></SENT>
<SENT sid="6" pm="."><plain>A patient with primary APS who developed <z:hpo ids='HP_0001650'>aortic stenosis</z:hpo> with vegetations on a bioprosthetic porcine valve is presented </plain></SENT>
</text></document>